Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Century Therapeutics reported Q1 2026 financial results and updates on its induced pluripotent stem cell (iPSC)-derived therapies. The company remains on track to submit an IND for CNTY-813, a type 1 diabetes islet therapy, by Q4 2026 with initial clinical data expected in the second half of 2027. Additionally, Century plans to initiate clinical tr…
Silexion Therapeutics announced the commencement of GMP clinical batch manufacturing for SIL204, their next-generation siRNA therapy targeting mutated KRAS in locally advanced pancreatic cancer. The company also received ethics committee approval from Tel Aviv Sourasky Medical Center to conduct a Phase 2/3 clinical trial of SIL204, marking critical…
Foremost Clean Energy Ltd. announced successful completion of its 2026 drilling program at the Hatchet Lake South Uranium Project in northern Saskatchewan, expanding the Tuning Fork Uranium Zone with multiple significant uranium mineralization intercepts. The program included 19 diamond drill holes with high-grade results supporting continued explo…
One Stop Systems, Inc. (Nasdaq: OSS), a US-based leader in rugged high performance AI and machine learning compute solutions for edge applications, announced its participation in Special Operations Forces Week from May 19 to 21, 2026. The company will demonstrate its rugged AI compute products designed for defense applications, collaborating with i…
Verrica Pharmaceuticals announced that its CEO will present at the H.C. Wainwright 4th Annual BioConnect Investor Conference held at NASDAQ, highlighting its dermatological therapeutics pipeline including FDA-approved YCANTH® for molluscum contagiosum and development programs for common warts and non-melanoma skin cancers.
Cerence Inc., a leader in conversational AI-powered automotive experiences, announced its participation in the TD Cowen 54th Annual Technology, Media & Telecom Conference. Its CEO and CFO will engage in a fireside chat and one-on-one investor meetings, highlighting company strategies and innovations in AI and automotive technology.
TTEC Digital has entered a strategic collaboration agreement with Amazon Web Services to enhance adoption of Amazon Connect by integrating AI-powered customer experience solutions, simplifying contact center modernization. This partnership aims to deliver intelligent self-service, agent assistance, and real-time data capabilities to organizations, …
Pacira BioSciences, a leader in non-opioid pain management therapies, announced its participation in analyst-led fireside chats at three major healthcare conferences in May and June 2026. The company highlighted its existing commercial products and ongoing clinical pipeline, including a gene therapy candidate in Phase 2 development for osteoarthrit…
electroCore announced new clinical findings published in JAMA Network Open demonstrating that adding the Quell electrical nerve stimulation device to outpatient physical therapy significantly reduces movement-evoked pain and fatigue in fibromyalgia patients, with benefits observed within 30 days and sustained up to six months.
Photronics, a global leader in photomask technologies, plans to report its fiscal second quarter 2026 financial results on May 28, 2026, before market open. The company will also hold a public conference call to discuss financial performance, business conditions, and industry outlook.
Abacus Global Management, a financial services company listed on the NYSE under ticker ABX, will participate in the 26th Annual B. Riley Investor Conference held May 20-21, 2026. Company executives will engage with investors to discuss their focus on alternative asset management, longevity-based assets, and personalized financial planning.
SailPoint, a leader in enterprise identity security, announced it will release its fiscal first quarter 2027 financial results on June 9, 2026, prior to the US market open. The company will host a conference call to discuss results and outlook, followed by an Investor Day event on June 16, featuring strategy, innovation, and financial presentations…
UroGen Pharma Ltd. announced positive 36-month duration of response data from its Phase 3 ENVISION trial of ZUSDURI (mitomycin) for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC). The Kaplan-Meier analysis showed 64.5% of patients achieving complete response at three months remained event-free at three years,…
INmune Bio announced it as a founding member of the American Biotech Innovation Alliance (ABIA), a coalition of biotechnology companies working to develop a national strategy to maintain and extend U.S. leadership in biotech innovation. The alliance will address key industry challenges such as manufacturing capacity, early research investment, regu…
nCino, Inc. released its inaugural AI in Banking Benchmark showing that 89% of senior banking executives foresee a dual workforce of AI agents and humans within five years. While AI adoption is widespread with 84% of banks using AI enterprise-wide, only 21% currently link AI investments to revenue gains. Data governance challenges remain a barrier …
Calidi Biotherapeutics announced that Dr. Antonio F. Santidrian, CSO, will present new data at the ASGCT conference highlighting the company's proprietary RedTail virotherapy platform and lead candidate CLD-401, which targets tumors via systemic delivery and exhibits immune activating properties. The company plans to file an IND for CLD-401 by the …
AirJoule Technologies Corporation, a NASDAQ-listed company specializing in technology that extracts water from air, will release its Q1 2026 financial results on May 14, 2026, followed by a conference call to discuss the results and answer questions on May 15, 2026. The company highlights its partnerships with GE Vernova and Carrier Global Corporat…
LiqTech International announced its Q1 2026 financial results showing a slight decline in revenue to $4.1 million compared to the prior year, and a net loss widening to $2.7 million. The company highlighted growth in commercial pool and marine water treatment markets along with a positive outlook expecting 39% to 64% revenue growth for full-year 20…
Protara Therapeutics announced its first quarter 2026 financial results with $177 million in cash and investments, supporting operations into 2028. The company plans to submit a Biologics License Application for TARA-002 in lymphatic malformations in the second half of 2027 and continues to advance clinical trials in non-muscle invasive bladder can…
Moleculin Biotech announced that the MIRACLE trial evaluating Annamycin plus cytarabine in relapsed/refractory acute myeloid leukemia (AML) is on track for first interim unblinding of data by June 30, 2026. Preliminary blinded data from 45 patients show a complete remission rate (~30%) approximately double historical rates for cytarabine alone. Rec…
Swarmer, Inc, a drone autonomy software company, reported its first quarter 2026 financial results following its successful Nasdaq IPO. The company raised $17.3 million and announced key contract wins and expansion into Japan. Despite these positive developments, revenue declined significantly due to the conclusion of a major customer engagement, w…
Diginex Limited appoints Archana Kotecha, founder of The Remedy Project, as Chief Impact Officer to enhance its human rights and supply chain due diligence capabilities amid a rapidly growing $9.6 billion market. The move supports Diginex's strategy to scale sustainable regulatory compliance solutions using advanced technologies and expands its glo…
ARS Pharmaceuticals has announced the appointment of Donn Casale as its new President, effective June 1, 2026. Casale brings 25 years of biopharmaceutical commercial leadership experience, having previously scaled successful healthcare products. His role will focus on overseeing global commercial operations and driving growth, particularly advancin…
NOVAGOLD Resources Inc. released its 2025 Sustainability Report detailing its environmental, social, and governance (ESG) performance aligned with global standards such as TCFD and TNFD. The report emphasizes NOVAGOLD's responsible advancement of the Donlin Gold project, strong community engagement, and commitment to sustainable mining development …
Esperion Therapeutics announced the presentation of new analyses at the European Atherosclerosis Society Congress 2026. The data highlights the efficacy of bempedoic acid in lowering LDL cholesterol in children with heterozygous familial hypercholesterolemia as well as factors enhancing LDL-C reduction in adults. These findings support advancing be…
